EarlySense Recognized For Advancing Continuous Monitoring of Patients on Opioids
WALTHAM, MA – June 15, 2016 – EarlySense, the market leader in contact-free continuous monitoring solutions, announced today that Tim O’Malley, president of EarlySense, Inc., accepted an award on behalf of the company at the AAMI 2016 Conference Awards Ceremony, which recognizes leaders and innovators whose efforts have moved the healthcare technology industry forward to improve patient care and safety.
The AAMI 2016 Conference Awards honored an impressive lineup of healthcare technology experts, patient safety champions, young professionals, and industry partners for their leadership, commitment, and contributions to the field.
Marilyn Neder Flack, Executive Director of the AAMI Foundation stated, “I am very grateful that EarlySense is a premiere partner with the AAMI Foundation in the National Coalition to Promote Continuous Monitoring of Patients on Opioids. This level of support and involvement in this critically important initiative demonstrates EarlySense’s commitment to ensuring no patient on opioids will have a poor outcome due to undetected opioid induced respiratory depression.”
EarlySense works closely with the AAMI Foundation to expand the messages and tools developed by the foundation’s National Coalition to Promote Continuous Monitoring of Patients on Opioids. The EarlySense System, used by medical facilities around the world, continuously monitors patient heart rate, respiratory rate and motion via an under-the-mattress sensor. It is designed to assist clinicians in identifying patient risk early, helping clinicians to reduce the chance of respiratory depression and decreasing the risk of complications, including patient death.
“Use of Opioid-based medications presents a risk which may significantly elevate the occurrence of adverse events due to respiratory depression, therefore continuous monitoring of these patients is critical,” said Tim O’Malley, President of EarlySense, Inc. “We are pleased to work alongside AAMI to raise awareness of this challenge, while continuing to expand the reach of our technology to improve healthcare safety across the country.”About EarlySense
EarlySense provides contact-free, continuous monitoring solutions for the medical and consumer digital health markets. EarlySense’s patented sensor and advanced algorithms monitor and analyze cardiac, respiratory, sleep and motion parameters. Used in hospitals and healthcare facilities worldwide, EarlySense assists clinicians in early detection of patient deterioration, helping to prevent adverse events, including code blues, preventable ICU transfers, patient falls and pressure ulcers.
The myEarlySense smart home-compatible consumer solution brings hospital-proven technology to the home, providing valuable data regarding wellness and sleep. myEarlySense OEM technology is at the core of wellness and sleep products marketed by international partners including Samsung, Beurer and iFit. EarlySense was founded in 2004 and has offices in Waltham, MA and Ramat Gan, Israel. For more information, please visit www.EarlySense.com and www.myEarlySense.com.About AAMI
The AAMI Foundation is a 501(c)3 charitable organization whose primary mission is to serve the public welfare and improve patient safety by fostering support and recognition for the advancement of healthcare technology management. It does this through the work of safety initiatives, the distribution of scholarships to students, global outreach initiatives, and awards for excellence. https://www.aami.org